RecruitingNCT07046260

Prospective Study to Assess a Diagnostic Aid for Cancer

Prospective Cohort Study With Case Enrichment to Assess a Diagnostic Aid for Cancer in Symptomatic Subjects (PROCARES)

Sponsor

Harbinger Health

Enrollment

1,650 participants

Start Date

Jul 11, 2025

Study Type

OBSERVATIONAL

Conditions

Cancer

Summary

The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.

Eligibility

Min Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood sample collection for people with cancer. The study is currently recruiting participants at 39 locations. People eligible for this study include aged 45 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood sample collection

The study will collect up to 40 mL of whole peripheral blood in Streck Cell-Free DNA BCT® tubes from each participant.

Locations(39)

Southern California Research Center

Coronado, California, United States

Palomar Health

Poway, California, United States

South Coast Gynecologic Oncology

San Diego, California, United States

Rocky Mountain Gastroenterology

Centennial, Colorado, United States

Zoyla Almeida, MD PA

Coconut Creek, Florida, United States

Azzi ENT and Facial Reconstructive Surgery

Jupiter, Florida, United States

Prophase, LLC

Margate, Florida, United States

Millennium Medical Research

Miami, Florida, United States

Regis Clinical Research

Miami, Florida, United States

Gastroenterology of Greater Orlando

Orange City, Florida, United States

Millennium Physician Group

Port Charlotte, Florida, United States

Stuart Oncology Associates

Stuart, Florida, United States

Avita Clinical Research

Tampa, Florida, United States

Cancer Center of Middle Georgia

Dublin, Georgia, United States

Pulmonary & Sleep Specialists of Northeast Georgia, P.C

Winder, Georgia, United States

Christie Clinic

Champaign, Illinois, United States

Hope and Healing Cancer Services

Hinsdale, Illinois, United States

Iowa Clinic

West Des Moines, Iowa, United States

Hutchinson Clinic

Hutchinson, Kansas, United States

Northlake Gastroenterology Associates

Hammond, Louisiana, United States

Velocity Clinical Research

Annapolis, Maryland, United States

Capital Digestive Care

Chevy Chase, Maryland, United States

Huron Gastroenterology

Ypsilanti, Michigan, United States

Oncology Hematology Specialists

Mountain Lakes, New Jersey, United States

Southwest Gastroenterology

Albuquerque, New Mexico, United States

Westchester Putnam Gastro

Carmel, New York, United States

Associated Gastroenterologists of Central New York

Fayetteville, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Wilmington Health, PLLC

Wilmington, North Carolina, United States

Hightower Clinical

Oklahoma City, Oklahoma, United States

Susquehanna Research Group

Harrisburg, Pennsylvania, United States

Respiratory Specialists

Wyomissing, Pennsylvania, United States

Cancer Care Associates of York

York, Pennsylvania, United States

GIA Clinical Trials, LLC

Knoxville, Tennessee, United States

Premier Family Physicians

Austin, Texas, United States

Texas Digestive

Harlingen, Texas, United States

Activian Clinical Research (Scarsdale)

Houston, Texas, United States

Huntsville Research Institute, LLC

Huntsville, Texas, United States

Activian Clinical Research

Kingwood, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07046260

Related Trials

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

NCT069702754 locations

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

NCT055615951 location

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

NCT064580365 locations

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

NCT066343813 locations

The Florida ASCENT Study

NCT070422431 location